Jena

Oncology Research

Advanced clinical trials focusing on multiple myeloma, prostate cancer, and gastric cancer treatments. Studies evaluating novel therapeutic combinations and targeted approaches for various cancer types.

Hematologic Malignancies
Solid Tumors
Targeted Therapies

Innovative treatments including antibody-drug conjugates and immunotherapy combinations for improved patient outcomes.

Cardiovascular Studies

Research investigating treatments for hypertrophic cardiomyopathy and advanced cardiovascular disease. Trials exploring new approaches to reduce major cardiovascular events and improve patient quality of life.

Heart Disease Management
Cardiovascular Risk Reduction
Novel Therapeutic Approaches

Focus on both preventive measures and treatment of established cardiovascular conditions.

Autoimmune Disorders

Clinical investigations of treatments for systemic lupus erythematosus, Sjögren’s Disease, and other autoimmune conditions. Studies evaluating new biological therapies and targeted treatments.

Inflammatory Diseases
Immunotherapy
Disease-Modifying Treatments

Comprehensive research into improving treatment outcomes for patients with chronic autoimmune conditions.

Study on Ketamine and CBASP for Treating Chronic Depression in Adults

Recruiting

2 1 1
Investigated drugs:
- Ketamine Hydrochloride
- Sodium Chloride
Study on ZED1227 for Improving Symptoms in Celiac Disease Patients on a Gluten-Free Diet

Recruiting

2 1
Investigated drugs:
- Methyl (E,6S)-7-[[1-[2-(2-Ethylbutylamino)-2-Oxoethyl]-2-Oxopyridin-3-Yl]Amino]-6-[(3-Methylimidazole-4-Carbonyl)Amino]-7-Oxohept-2-Enoate
+3
Study on Mosunetuzumab and Lenalidomide for Patients with Untreated Follicular Lymphoma

Recruiting

3 1 1 1
Investigated diseases:
- Follicular lymphoma
Investigated drugs:
Study on the Effectiveness and Safety of Perampanel for Children with Epilepsy

Recruiting

2 1 1 1
Investigated drugs:
- Perampanel
Study Comparing Elranatamab to Drug Combinations for Patients with Relapsed/Refractory Multiple Myeloma After Anti-CD38 Therapy

Recruiting

3 1 1 1
Investigated drugs:
+10
Study of KYV-101 Therapy for Patients with Refractory Generalized Myasthenia Gravis

Recruiting

4 1 1 1
Investigated diseases:
- Myasthenia gravis
Investigated drugs:

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Pembrolizumab Cyclophosphamide Carboplatin Cisplatin Dexamethasone Vincristine Sulfate Etoposide Cytarabine Rituximab Lenalidomide Prednisolone Docetaxel Prednisone Doxorubicin Hydrochloride Fluorouracil Ifosfamide Fludarabine Phosphate Mycophenolate Mofetil Oxaliplatin Bortezomib Ruxolitinib Nivolumab Tacrolimus Methotrexate Thiotepa Enzalutamide Gemcitabine Capecitabine Busulfan Obinutuzumab Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acute graft versus host disease Acute graft versus host disease in intestine Acute graft versus host disease in liver Acute graft versus host disease in skin Acute kidney injury Acute lymphocytic leukaemia Acute lymphocytic leukaemia recurrent Acute myeloid leukaemia Acute myocardial infarction Acute on chronic liver failure Acute respiratory distress syndrome Adenocarcinoma gastric Adenocarcinoma pancreas Allogenic stem cell transplantation Alveolar rhabdomyosarcoma Amyotrophic lateral sclerosis Anaplastic large cell lymphoma T- and null-cell types Angiosarcoma Angiosarcoma metastatic Angiosarcoma non-metastatic Angiosarcoma recurrent Aortic valve replacement Arteriosclerosis Asthma Atrial fibrillation Atypical teratoid/rhabdoid tumour of CNS B-cell lymphoma B-cell small lymphocytic lymphoma B-cell small lymphocytic lymphoma recurrent B-cell small lymphocytic lymphoma refractory Back pain Bladder cancer Bladder transitional cell carcinoma Bladder transitional cell carcinoma stage IV Breast angiosarcoma Breast angiosarcoma metastatic Breast cancer Breast cancer female Bronchiectasis Cardiac amyloidosis Cardiac failure Cardiac failure acute Cardiac function disturbance postoperative Cardiomyopathy Central nervous system lymphoma Cerebrovascular accident prophylaxis Cervix carcinoma Cholangiocarcinoma Cholangiosarcoma Chronic graft versus host disease Chronic graft versus host disease in intestine Chronic graft versus host disease in liver Chronic graft versus host disease in skin Chronic kidney disease Chronic lymphocytic leukaemia Chronic lymphocytic leukaemia recurrent Chronic lymphocytic leukaemia refractory Chronic myeloid leukaemia Chronic rhinosinusitis with nasal polyps Clear cell renal cell carcinoma Clostridium difficile infection Coeliac disease Colitis ulcerative Colon cancer stage II Colon cancer stage III Colon cancer stage IV Colorectal adenocarcinoma Colorectal cancer metastatic Colorectal cancer stage IV Congenital cystic kidney disease Conjunctivitis allergic Coronary artery disease Crohn's disease Cystic fibrosis Cystic fibrosis gastrointestinal disease Cystic fibrosis respiratory infection suppression Deafness neurosensory Dedifferentiated liposarcoma Dementia Alzheimer's type Depression Diabetic nephropathy Diffuse large B-cell lymphoma Diffuse large B-cell lymphoma recurrent Diffuse large B-cell lymphoma refractory Encephalitis autoimmune Endometrial cancer Ependymoma Epilepsy Escherichia urinary tract infection Essential thrombocythaemia Ewing's sarcoma Fallopian tube cancer Fallopian tube cancer stage III Fallopian tube cancer stage IV Fibrosarcoma Fibrosarcoma metastatic Follicle centre lymphoma follicular grade I II - III refractory Follicular lymphoma Follicular lymphoma stage I Follicular lymphoma stage II Follicular lymphoma stage III Gallbladder cancer Gastrectomy Gastric cancer Gastrooesophageal cancer Generalised tonic-clonic seizure Germ cell cancer Glioblastoma Glioma Glomerulonephritis membranoproliferative Graft versus host disease Head and neck cancer Head and neck cancer metastatic Head and neck cancer stage III Head and neck cancer stage IV Hepatic angiosarcoma Hepatic cirrhosis Hepatitis alcoholic Hepatocellular carcinoma Hepatorenal syndrome HER2 positive gastric cancer Herpes simplex High-grade B-cell lymphoma Hodgkin's disease Hormone receptor positive breast cancer Hormone receptor positive HER2 negative breast cancer Hormone-dependent prostate cancer Hormone-refractory prostate cancer Human epidermal growth factor receptor negative Hypercholesterolaemia Hypertrophic cardiomyopathy IgA nephropathy Immune thrombocytopenia Immune-mediated myositis Indolent systemic mastocytosis Infection in an immunocompromised host Insomnia Ischaemic stroke Laryngeal cancer Leiomyosarcoma Leiomyosarcoma metastatic Leiomyosarcoma recurrent Leukaemia Liposarcoma Liposarcoma metastatic Liposarcoma recurrent Liver transplant Lower respiratory tract infection Lung neoplasm malignant Lupus nephritis Lymphangiosarcoma Magnetic resonance imaging Major depression Malignant peritoneal neoplasm Mantle cell lymphoma recurrent Mantle cell lymphoma refractory Marginal zone lymphoma recurrent Marginal zone lymphoma refractory Medication overuse headache Medulloblastoma Metastatic gastric cancer Metastatic renal cell carcinoma Migraine Migraine with aura Migraine without aura Mixed-type liposarcoma Multiple sclerosis Myasthenia gravis Myelodysplastic syndrome Myelofibrosis Myxofibrosarcoma Myxoid liposarcoma Nasopharyngeal cancer Neonatal alloimmune thrombocytopenia Neoplasm Neoplasm malignant Nephroblastoma Nervous system disorder Neuroblastoma Non-Hodgkin's lymphoma Non-obstructive cardiomyopathy Non-small cell lung cancer Non-small cell lung cancer metastatic Non-small cell lung cancer stage II Non-small cell lung cancer stage III Non-small cell lung cancer stage IIIA Non-small cell lung cancer stage IIIB Non-small cell lung cancer stage IV Oesophageal adenocarcinoma Oesophageal cancer metastatic Oesophageal carcinoma Oesophageal squamous cell carcinoma Ovarian cancer Ovarian cancer stage III Ovarian cancer stage IV Pancreatic carcinoma Pancreatic carcinoma metastatic Pancreatic carcinoma stage IV Pancreatic neoplasm Paranasal sinus inflammation Plasma cell myeloma Plasma cell myeloma refractory Pleomorphic leiomyosarcoma Pleomorphic liposarcoma Polycythaemia vera Post-acute COVID-19 syndrome Primary mediastinal large B-cell lymphoma Primary myelofibrosis Primary progressive multiple sclerosis Progressive multiple sclerosis Prophylaxis against transplant rejection Prostate cancer Prostate cancer metastatic Prostate cancer recurrent Prostate cancer stage IV Pulmonary arterial hypertension Rectal cancer stage II Renal cancer metastatic Renal cell carcinoma Renal cell carcinoma stage IV Rhabdomyosarcoma Rhabdomyosarcoma recurrent Rheumatoid arthritis Richter's syndrome Round cell liposarcoma Secondary progressive multiple sclerosis Sepsis Septic shock Severe myoclonic epilepsy of infancy Sinusitis noninfective Sjogren's syndrome Skin angiosarcoma Small intestine leiomyosarcoma Squamous cell carcinoma of head and neck Squamous cell carcinoma of the hypopharynx Staphylococcal bacteraemia Synovial sarcoma Synovial sarcoma metastatic Synovial sarcoma recurrent Systemic candida Systemic lupus erythematosus Systemic scleroderma Testicular leiomyosarcoma Thalassaemia Thrombocytopenia Thrombosis prophylaxis Thrombotic thrombocytopenic purpura Transitional cell cancer of renal pelvis and ureter metastatic Transitional cell cancer of the renal pelvis and ureter Transitional cell carcinoma Transitional cell carcinoma metastatic Transitional cell carcinoma urethra Triple negative breast cancer Trisomy 21 Undifferentiated sarcoma Uterine leiomyosarcoma Waldenstrom's macroglobulinaemia recurrent Waldenstrom's macroglobulinaemia refractory Warm autoimmune haemolytic anaemia

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes